Tycho Heimbach MS, PhD, FAAPS

Dr. Tycho Heimbach is a Senior Principal Scientist and Director at Merck in the USA. He was a Director at Novartis where he has led a global PBPK modeling group in PK Sciences and serves as a PBPK and biopharmaceutics expert. He received his PhD in Pharmaceutics from the University of Michigan. Currently, he chairs a global team that reviews and makes recommendations and conducts PBPK predictions to inform clinical trials, including pediatric studies, within the global PK Sciences function.

His responsibilities include addressing regulatory questions in pediatric drug development. Moreover, his duties include development of translational biopharmaceutical formulation and PBPK/PD strategies across all disease areas. He served as the Novartis representative on PBPK WGs for PBPK Modeling and the PBPK renal and hepatic impairment for the Innovation and Quality in Pharmaceutical Development (IQ) consortium.